Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro

Immunology

Volumn 92, Issue 4, 1997, Pages 478-486

  Schebesch, C ^a   Kodelja, V ^a   Muller C ^a   Hakij, N ^a   Bisson, S ^a   Orfanos, C E ^a   Goerdt, S ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; BUCLADESINE; CALCIMYCIN; CD4 ANTIGEN; CHOLERA TOXIN; DIBUTYRYL CYCLIC GMP; FORSKOLIN; INTERLEUKIN 10; NEUTRALIZING ANTIBODY; PERTUSSIS TOXIN; PROPRANOLOL;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECOND MESSENGER; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0030734165     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00371.x     Document Type: Article

References (83)

1. STEIN M., KESHAV S., HARRIS N. & GORDON S. (1992) Interleukin-4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176, 287.
2. BECKER S. & DANIEL E.G. (1990) Antagonistic effects of IL-4 and interferon-gamma on human monocytes and macrophages: effects on Fc receptors, HLA-D antigens, and superoxide production. Cell Immunol 129, 351.
3. TE VELDE A.A., HUIJBENS R.J.F., DE VRIES J.E. & FIGDOR C.G. (1990) IL-4 decreases FcγR membrane expression and FcγR-mediated cytotoxic activity of human monocytes. J Immunol 144, 3046.
4. COWAN H.B., VICK S., CONARY J.T. & SHEPHERD V.L. (1992) Dexamethasone upregulates mannose receptor activity by increasing mRNA levels. Arch Biochem Biophys 296, 314.
5. CONRAD D.J., KUHN H., MULKINS M., HIGHLAND E. & SIGAL E. (1992) Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci USA 89, 217.
6. 2. Proc Natl Acad Sci USA 86, 3803.
7. HART P.H., WHITTY G.A., BURGESS D.R., CROATTO M. & HAMILTON J.A. (1990) Augmentation of glucocorticoid action on human monocytes by interleukin-4. Lymphokine Res 9, 147.
8. CHEUNG D.L., HART P.H., VITTI G.F., WHITTY G.A. & HAMILTON J.A. (1990) Contrasting effects of interferon-γ and interleukin-4 on the interleukin-6 activity of stimulated human monocytes. Immunology 71, 70.
9. GOERDT S., BHARDWAJ R. & SORG C. (1993) Inducible expression of MS-1 high molecular weight protein by endothelial cells of continuous origin and by dendritic cells, macrophages in vivo and in vitro. Am J Pathol 142, 1409.
10. LANDMANN R., FISSCHER A.E. & OBRECHT J.-P. (1992) Interferon-gamma and interleukin-4 down-regulate soluble CD14 release in human monocytes and macrophages. J Leukoc Biol 52, 323.
11. DELESPESSE G. & SARFATI M. (1991) An update on human CD23 (FcεRII). FcεRII and IgE-BFs (soluble CD23) play an essential role in the regulation of human IgE synthesis. Clin Exp Allergy 21 (supple 1), 153.
12. GOERDT S., WALSH D.J., MURPHY G.F. & POBER J.S. (1991) Identification of a novel high molecular weight protein antigen preferentially expressed by sinusoidal endothelial cells in normal human tissues. J Cell Biol 113, 1425.
13. + dermal perivascular dendritic cells. Lab Invest 65, 732.
14. GOERDT S., KOLDE G., BONSMANN G. et al. (1993) Immunohistochemical comparison of cutaneous histiocytoses and related skin disorders: diagnostic and histogenetic relevance of MS-1 high molecular weight protein expression. J Pathol 170, 421.
15. ZWADLO G., VOEGELI R., SCHULZE-OSTHOFF K. & SORG C. (1987) A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp Cell Biol 55, 295.
16. WENZEL I., ROTH J. & SORG, C. (1996) Identification of a novel surface molecule. RM 3/1, that contributes to the adhesion of glucocorticoid-induced human monocytes to endothelial cells. Eur J Immunol 26, 2758.
17. GOERDT S., KODELJA V., SCHMUTH M., ORFANOS C.E. & SORG C. (1996) The mononuclear phagocyte-dendritic cell dichotomy: myths, facts, and a revised concept. Clin Exp Immunol 105, 1-9.
18. KODELJA V. & GOERDT S. (1994) Dissection of macrophage differentiation pathways in cutaneous macrophage disorders and in vitro. Exp Dermatol 3, 257.
19. TOPOLL H., ZWADLO G., LANGE D.E. & SORG C. (1989) Phenotypic dynamics of macrophage subpopulations during human experimental gingivitis. J Periodontal Res 24, 106.
20. SZEKANECZ Z., HAINES G.K., LIN T.R. et al. (1994) Differential distribution of intercellullar adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum 37, 221.
21. DJEMADJI-OUDJIEL N., GOERDT S., KODELJA V., SCHMUTH M. & ORFANOS C.E. (1996) Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+++, MS-1 +/-, 25F9-) in psoriatic dermis. Arch Dermatol Res 288, 757.
22. COOPER A.M., DALTON D.K., STEWART T.A., GRIFFIN J.P., RUSSEL D.G. & ORME I.M. (1993) Disseminated tuberculosis in interferon-gamma gene-disrupted mice. J Exp Med 178, 2243.
23. KODELJA V., MÜLLER C., TENORIO S., SCHEBESCH C., ORFANOS C.E. & GOERDT S. (1997) Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiol 197, 478.
24. ZWADLO-KLARWASSER G., BENT S., HAUBECK H.-D., SORG C. & SCHMUTZLER W. (1990) Glucocorticoid-induced appearance of the macrophage subtype RM 3/1 in peripheral blood in man. Int Arch Allergy Appl Immunol 91, 175.
25. OEHLER J.R., HERBERMAN R.B. & CAMPBELL J.Y. (1977) Inhibition of rat mixed lymphocyte cultures by suppressor macrophages. Cell Immunol 29, 238.
26. WEBB P.J. & BROOKS C.G. (1980) Macrophage-like suppressor cells in rats. Cell Immunol 52, 370.
27. LICHTENSTEIN A., MURAHATA R., TERPENNING M., CANTRELL J. & ZIGHELBOIM J. (1981) Activation and mechanism of action of suppressor macrophages. Cell Immunol 64, 150.
28. VEIT B.C. (1982) Immunoregulatory activity of culture-induced suppressor macrophages. Cell Immunol 72, 14.
29. ETTENSOHN D.B., LALOR P.A. & ROBERTS N. (1988) Human alveolar macrophage suppression of lymphocyte proliferation. Am Rev Respir Dis 137, 765.
30. STOUT R.D. & FISHER M. (1983) Suppression of lymphocyte proliferative responses: demonstration of two stages occurring in the in vitro generation of suppressor macrophages. J Immunol 130, 1580.
31. PRETELL J.O. & FALCHUK Z.M. (1986) Generation of supressor macrophages during the human autologous mixed lymphocyte reaction. Clin Exp Immunol 65, 158.
32. SESTINI P., TAGLIABUE A. & BORASCHI D. (1984) Modulation of macrophage suppressive activity and prostaglandin release by lymphokines and interferon: comparison of alveolar, pleural and peritoneal macrophages. Clin Exp Immunol 58, 573.
33. 2-producing suppressor macrophages. Immunobiol 161, 385.
34. KENNARD J. & ZOLLA-PAZNER S. (1980) Origin and function of suppressor macrophages in myeloma. J Immunol 124, 268.
35. TARAMELLI D., HOLDEN H.T. & VARESIO L. (1981) In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation. J Immunol 126, 2123.
36. MIZUSHIMA Y., WEPSIC H.T., YAMAMURA Y. & DESILVA M.A. (1984) Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses. Clin Exp Immunol 57, 371.
37. CHANG Z.-L., BONVINI E., VARESIO L., HOLDEN H.T. & HERBERMAN R.B. (1988) Differential in vitro modulation of suppressor and antitumor functions of mouse macrophages by lymphokines and/or endotoxin. Cell Immunol 114, 282.
38. FAIS S., BURGIO V.L., SILVESTRI M., CAPOBIANCHI M.R., PACCHIAROTTI A. & PALLONE F. (1994) Multinucleated giant cells generation induced by interferon-γ. Lab Invest 71, 737.
39. SHIBATA Y., SHIBUYA E. & ISHIDA N. (1984) Relationships between suppressor macrophages and macrophage precursors in the spleens from tumor-bearing mice. Cell Immunol 85, 45.
40. FUJII T., IGARASHI T. & KISHIMOTO S. (1987) Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice. JNCI 78, 509.
41. SAHA B., DAS G., VOHRA H., GANGULY N.K. & MISHRA G.C. (1994) Macrophage-T cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response. Eur J Immunol 24, 2618.
42. GOSSELIN D., TURCOTTE R. & LEMIEUX S. (1995) Cellular target of in vitro-induced suppressor cells derived from the spleen of mycobacterium lepraemurium-infected mice and role of IFN-γ in their development. J Leukoc Biol 57, 122.
43. LEMIEUX S., GOSSELIN D., LUSIGNAN Y. & TURCOTTE R. (1990) Early accumulation of suppressor cell precursors in the spleen of Mycobacterium lepraemurium-infected mice and analysis of their in vitro-induced maturation. Clin Exp Immunol 81, 116.
44. KIRSCHMANN D.A., MURASKO X.H. & MURASKO D.M. (1994) Inhibition of macrophage-induced, antigen-specific T-cell proliferation by poly I:C role of suppressor macrophages. Immunology 82, 238.
45. MARCINKIEWICZ J. & PTAK W. (1980) Macrophage suppressor factor in contact sensitivity. Mechanisms of its release and action. Immunology 41, 211.
46. NAKANO Y. & NAKANO K. (1985) Non-specific regulatory mechanism of contact sensitivity: induction of macrophage-like suppressor cells and their factors with hapten-conjugated lymphoid cells. Immunology 54, 297.
47. PTAK W., ZEMBALA M. & GERSHON R.K. (1978) Intermediary role of macrophages in the passage of suppressor signals between T-cell subsets. J Exp Med 22, 424.
48. SZCZEPANIK M., BRYNIARSKI K., PRYJMA J. & PTAK W. (1993) Distinct populations of antigen-presenting macrophages are required for induction of effector and regulatory cells in contact sensitivity response in mice. J Leukoc Biol 53, 320.
49. KNOP J., MALORNY U., MICHELS E. & SORG C. (1984) Selection of delayed hypersensitivity T effector and T suppressor cell response by antigen presenting macrophages. Immunobiol 168, 246.
50. KNOP J., MALORNY U. & MACHER E. (1984) Selective induction of delayed hypersensitivity T-effector and T-suppressor lymphocytes by in vitro haptenized bone marrow-derived macrophages. Cell Immunol 88, 411.
51. KNOP J., TABORSKI B. & DE MAEYER-GUIGNARD J. (1987) Selective inhibition of the generation of T suppressor cells of contact sensitivity in vitro by interferon. J Immunol 136, 3684.
52. CHANG M.-D.Y., POLLARD J.W., KHALILI H., GOYERT S.M. & DIAMOND B. (1993) Mouse placental macrophages have a decreased ability to present antigen. Immunology 90, 462.
53. MUES B., LANGER D., ZWADLO G. & SORG C. (1989) Phenotypic characterization of macrophages in human term placenta. Immunology 67, 303.
54. SUTTON L., GADD M., MASON D.Y. & REDMAN C.W.G. (1986) Cells bearing class II MHC antigens in the human placenta and amniochorion. Immunology 58, 23.
55. POULTER L.W., JANOSSY G., POWER C., SREENAN S. & BURKE C. (1994) Immunological/physiological relationships in asthma: potential regulation by lung macrophages. Immunol Today 15, 258.
56. FIREMAN E.M., EFRAIM S.B., GREIF J., KIVITY S. & TOPILSKY M.R. (1988) Suppressor cell activity of human alveolar macrophages in interstitial lung diseases. Clin Exp Immunol 73, 111.
57. GEERTSMA M.H., TEEUW W.L., NIBBERING P.M. & VAN FURTH R. (1994) Pulmonary surfactant inhibits activation of human monocytes by recombinant interferon-γ. Immunology 82, 450.
58. HOLT P.G., SCHON-HEGARD M.A. & OLIVER J. (1988) MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations. J Exp Med 167, 262.
59. SPITERI M.A., KNIGHT R.A., JEREMY J.Y., BARNES P.J. & CHUNG K.F. (1994) Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. Eur Respir J 7, 1431.
60. CLARE-SALZLER M.J., BROOKS J., CHAI A., VAN HERLE K. & ANDERSON C. (1992) Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest 90, 741.
61. ENK A.H., ANGELONI V.L., UDEY M.C. & KATZ S.I. (1993) Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for 1L-10 in induction of tolerance. J Immunol 151, 2390.
62. CAUX C., MASSACRIER C., VANBERVLIET B., BARTHELEMY C., LIU Y.-J. & BANCHEREAU J. (1994) Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol 6, 1177.
63. BEISSERT S., HOSOI J., GRABBE S., ASAHINA A. & GRANSTEIN R.D. (1995) IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol 154, 1280.
64. MITRA R.S., JUDGE T.A., NESTLE F.O., TURKA L.A. & NICKOLOFF B.J. (1995) Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. J Immunol 154, 2668.
65. BUELENS C., VERHASSELT V., DE GROOTE D., THIELEMANS K., GOLDMANN M. & WILLEMS F. (1997) Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and ganulocyte/macrophage colony-stimulating factor. Eur J Immunol 27, 756.
66. + T cell proliferation in vitro. J Immunol 154, 151.
67. NESTLE F.O., TURKA L.A. & NICKOLOFF B.J. (1994) Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of TH1 typé cytokines. J Clin Invest 94, 202.
68. VOLLMER S., MENSSEN A., TROMMLER P., SCHENDEL D. & PRINZ J.C. (1994) T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 24, 2377.
69. UYEMURA K., YAMAMURA M., FIVENSON D.F., MOULIN R.L. & NICKOLOFF B.J. (1993) The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 101, 701.
70. SCHLAAK J.F., BUSLAU M., JOCHUM W. et al. (1994) T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102, 145.
71. BARNA M., SNIJDEWINT F.G.M., VAN DER HEIJDEN F.L., BOS J.D. & KAPSENBERG M.L. (1994) Characterization of lesional psoriatic skin T lymphocyte clones. Acta Derm Venereol (Stockh) 186 (suppl), 9.
72. 2 release and inducing interleukin 1 production. J Immunol 133, 764.
73. SCHMIDT PAK A., IP G., WRIGHT M.A. & YOUNG M.R.I. (1995) Treating tumor-bearing mice with low-dose γ-interferon plus tumor necrosis factor-α to diminish immune suppressive granulocyte macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy. Cancer Res 55, 885.
74. ENK A., SALOGA J., BECKER D., MOHAMADZADEH M. & KNOP J. (1994) Induction of hapten-specific tolerance by interleukin 10 in vivo. J Exp Med 179, 1397.
75. MILLS C.D. (1991) Molecular basis of 'suppressor' macrophages. J Immunol 146, 2719.
76. 2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181, 775.
77. 2. J Exp Med 180, 2365.
78. LIEW F.Y., LI Y., SEVERN A., MILLOTT S., SCHMIDT J., SALTER M. & MONCADA S. (1991)A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur J Immunol 21, 2489.
79. MODOLELL M., CORRALIZA I.M., LINK F., SOLER G. & EICHMANN K. (1995) Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 25, 1101.
80. NAJAR H.M., RUHL S., BRU-CAPDEVILLE A.C. & PETERS J.H. (1990) Adenosine and its derivatives control human monocyte differentiation into highly accessory cells versus macrophages. J Leukoc Biol 47, 429.
81. ASAHINA A., MORO O., HOSOI J. et al. (1995) Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects. Proc Natl Acad Sci USA 92, 8323.
82. LO C-J., GARCIA I., CRYER H.G. & MAIER R.V. (1996) Calcium and calmodulin regulate lipopolysacchride-induced alveolar macrophage production of tumor necrosis factor and procoagulant activity. Arch Surg 131, 44.
83. DIETER P. & FITZKE E. (1995) Differential regulation of phospholipase D and phospholipase C by protein kinase C-β and -δ in liver macrophages. Cell Signal 7, 687.